Disease-Free Survival Long-term (1 and 2 year) [clinicaltrials_resource:27de78e5a27728600fd8d19671a27c54]
is the length of time during and after medication or treatment during which the disease being treated (usually cancer) does not get worse. It is sometimes used as a metric to study the health of a person with a disease to try to determine how well a new treatment is working.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Disease-Free Survival Long-term (1 and 2 year) [clinicaltrials_resource:27de78e5a27728600fd8d19671a27c54]
is the length of time during and after medication or treatment during which the disease being treated (usually cancer) does not get worse. It is sometimes used as a metric to study the health of a person with a disease to try to determine how well a new treatment is working.
Bio2RDF identifier
27de78e5a27728600fd8d19671a27c54
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:27de78e5a27728600fd8d19671a27c54
measure [clinicaltrials_vocabulary:measure]
Disease-Free Survival
time frame [clinicaltrials_vocabulary:time-frame]
Long-term (1 and 2 year)
description
is the length of time during a ...... ll a new treatment is working.
identifier
clinicaltrials_resource:27de78e5a27728600fd8d19671a27c54
title
Disease-Free Survival Long-term (1 and 2 year)
@en
type
label
Disease-Free Survival Long-ter ...... e78e5a27728600fd8d19671a27c54]
@en